HAB Pharmaceuticals
Diabetes Care1X15 Tablet
Prescription required
This medicine is dispensed only against a valid prescription from a registered medical practitioner. You’ll be asked to upload it at checkout, and a pharmacist reviews it before dispatch.
Prescription policyYou save ₹165.00 · Inclusive of all taxes
SITAJAN MET 50/1000 is a tablet formulation containing Sitagliptine 50 mg and Metformin 1000 mg. Manufactured by HAB Pharmaceuticals in India. Supplied as strip-packed tablets.
Available on order. The seller arranges supply before dispatch.
SITAJAN MET 50/1000 is a combination tablet that contains SITAGLIPTINE 50 mg and METFORMIN 1000 mg. The product is presented in strip packing and is manufactured by HAB Pharmaceuticals in India. This introduction conveys the product composition, pharmaceutical form and manufacturer information as supplied by the vendor. For specific medical guidance, dosing and indication-related information, please refer to the product label or consult a healthcare professional.
SITAJAN MET 50/1000 is a fixed-dose tablet combining SITAGLIPTINE 50 mg and METFORMIN 1000 mg manufactured by HAB Pharmaceuticals in India. The product is supplied in strip packaging in tablet form. This listing provides factual product details such as composition, form, brand, packing type and country of origin. For clinical uses, dosing instructions, contraindications, side effects, and other medical details, consult the packaged product label, your prescribing doctor, or a pharmacist. This content does not provide therapeutic recommendations or clinical claims and is limited to vendor-supplied product facts.
This product sheet does not list specific medical uses, indications or clinical recommendations. For information about the conditions this medicine is prescribed for, appropriate patient selection, and expected outcomes, consult the product leaflet, the prescribing doctor, or a pharmacist. They can provide authoritative guidance on whether this medicine is suitable for an individual patient and how it fits into an overall treatment plan.
This product description provides only the factual composition and manufacturing details for SITAJAN MET 50/1000. Specific therapeutic benefits, clinical indications or expected outcomes are not provided here. For information about what this medicine is prescribed for and the benefits you may expect when taking it, consult the product leaflet, your prescribing doctor, or a qualified pharmacist.
SITAGLIPTINE 50 mg + METFORMIN 1000 mg (per tablet). Active ingredients listed by vendor: SITAGLIPTINE 50 mg; METFORMIN 1000 mg.
Follow the instructions on the prescription and the product label. Do not change the dose, frequency, or method of administration without first consulting the prescribing doctor or a pharmacist. If you have questions about when or how to take the tablet (for example, timing with meals), check the packaged leaflet or contact the prescribing clinician or pharmacist for specific directions tailored to your situation.
Read the product label and accompanying leaflet carefully before use. Only take this medicine as prescribed by a qualified healthcare professional. Inform your prescriber and pharmacist about all current medications, supplements, allergies, and medical conditions. Do not share this medicine with others. Store out of reach of children. If you experience any unexpected symptoms or concerns after starting the medicine, stop taking it only if advised and contact your doctor or seek medical attention immediately. This listing does not provide a list of potential side effects. For authoritative information about possible adverse reactions, warnings and precautions associated with SITAJAN MET 50/1000, please consult the product leaflet provided with the medicine, speak with your prescribing doctor, or ask a pharmacist. If you experience any unexpected symptoms after taking the medicine, seek medical advice promptly.
This product summary does not provide a list of contraindications or specific warnings. Before taking this medicine, review the product leaflet and discuss any health conditions, allergies, or current medications with your prescriber or pharmacist. If you notice any unusual symptoms after taking the medicine, contact your healthcare provider promptly. For pregnancy, breastfeeding, pediatric or geriatric considerations, consult the prescribing clinician or pharmacist for individualized advice. No interaction data is provided in the vendor-supplied facts. For information on potential interactions with other medicines, supplements or foods, consult the product leaflet, your prescribing doctor, or a pharmacist. Always disclose all current medications and supplements to the healthcare professional who prescribed this medicine so they can assess for any possible interactions and advise on safe use.
Store SITAJAN MET 50/1000 in its original packaging, in a cool, dry place as indicated on the product label. Keep the medicine away from direct heat, moisture and sunlight, and out of reach of children. Check the product packaging or leaflet for specific storage temperature recommendations and the expiry date. For disposal of expired or unused medicine, follow local regulations or ask a pharmacist for guidance.
Returns and cancellations follow our return policy. Availability and prescription checks are confirmed at checkout.
SITAJAN MET 50/1000 is listed as a medicine. Use it only as directed by a registered medical practitioner.
Yes. It is dispensed only against a valid prescription from a registered medical practitioner, which you upload at checkout.
Store SITAJAN MET 50/1000 in its original packaging, in a cool, dry place as indicated on the product label. Keep the medicine away from direct heat, moisture and sunlight, and out of reach of children. Check the product packaging or leaflet for specific storage temperature recommendations and the expiry date. For disposal of expired or unused medicine, follow local regulations or ask a pharmacist for guidance.